Zimmer Biomet

$119.83 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Zimmer Biomet

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Stock Analysis

last close $119.83
1-mo return -2.5%
3-mo return -2.5%
avg daily vol. 1.34M
52-week high 164.9
52-week low 105.23
market cap. $24.6B
forward pe 17.7
annual div. 0.96
roe 1.8%
ltg forecast 7%
dividend yield 0.8%
annual rev. $7.7B
inst own. 93.2%

Subscribe now for daily local and international financial news